New! Sign up for our free email newsletter.

Tuberculosis News

March 29, 2024

Top Headlines

 

A study has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery. The study leverages decades of cancer research to study tuberculosis-affected lung tissue and improve ...
Millions of people are spreading tuberculosis unknowingly - now scientists say they are close to developing a new test that is as simple as the lateral flows used during the Covid ...
Scientists have uncovered important clues to how human T cells combat Mycobacterium tuberculosis, the bacterium that causes ...
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide -- and that number is only growing larger. How, exactly, ...

Latest Headlines

updated 10:42am EDT

Earlier Headlines

 

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone. One in five incident TB cases were attributable to malnutrition, more than ...

Researchers have found that the body's process of removing old and damaged cell parts, is also an essential part of tackling infections that take hold within our cells, like TB. If this natural ...

A team of faculty has discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection ...

Neutrophils induce anti-inflammatory -- or M2 -- macrophages deep in their granulocyte core. The dense globular structures of granulomas in animals, particularly in the lungs, have been studied. ...

The microbes responsible for some infections can rapidly mutate into variants that evade detection and treatment. Now, a newly developed procedure could help researchers catch up to these sneaky ...

A research team has developed a novel chemical tool to reveal how bacteria adapt to the host environment and control host cells. This tool can be used to investigate bacterial interactions with the ...

Findings in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB ...

Researchers have designed and synthesized analogs of a new antibiotic that is effective against multidrug-resistant bacteria, opening a new front in the fight against these ...

Researchers hope their genome-assembly tool will spur the development of new treatments for bacterial ...

The bacterium that causes tuberculosis has a cousin you've never heard of: MAC. This bacterial complex is everywhere, but most people never show symptoms. Yet some people get very, very sick. ...

Researchers used data from large studies that contained laboratory measurements of two-drug combinations of 12 anti-tuberculosis drugs. Using mathematical models, the team discovered a set of rules ...

A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists to treat a potentially lethal lung infection and greatly reduce side effects of one ...

Many bladder cancer patients cannot tolerate the strong side effects of the gold standard treatment. Researchers have found a way to minimize those side effects and are poised to move into clinical ...

Researchers are hoping the results of a new study will spur a larger scale study of the effects of the BCG vaccine in patients with type 1 diabetes, considered among the most vulnerable groups to ...

An international consortium analyzed the genetic sequences and antibiotic susceptibility of more than 10,000 global Mycobacterium tuberculosis ...

Amid debate on the effectiveness of the tuberculosis vaccine, a new study suggests that the vaccine is protective against TB in children under 5, but adolescents and adults in high-burden countries ...

Research in animal models showed the potential of delivering a TB drug with one injection that lasts at least four months, in lieu of the current standard treatment requiring constant adherence to a ...

The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed ...

Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe's population. Treatment ...

Tuesday, February 27, 2024

Friday, January 12, 2024

Thursday, March 23, 2023

Monday, March 13, 2023

Thursday, March 9, 2023

Wednesday, February 15, 2023

Tuesday, January 31, 2023

Friday, January 27, 2023

Tuesday, December 20, 2022

Friday, December 16, 2022

Monday, October 3, 2022

Wednesday, September 14, 2022

Thursday, September 8, 2022

Monday, August 22, 2022

Monday, August 15, 2022

Thursday, August 11, 2022

Tuesday, August 9, 2022

Monday, August 8, 2022

Tuesday, August 2, 2022

Thursday, July 21, 2022

Wednesday, June 22, 2022

Tuesday, June 21, 2022

Wednesday, June 1, 2022

Tuesday, May 31, 2022

Wednesday, May 25, 2022

Monday, May 9, 2022

Wednesday, April 27, 2022

Tuesday, April 26, 2022

Saturday, April 16, 2022

Wednesday, March 30, 2022

Thursday, March 24, 2022

Monday, March 21, 2022

Friday, February 25, 2022

Tuesday, February 15, 2022

Wednesday, December 15, 2021

Tuesday, November 23, 2021

Saturday, August 21, 2021

Thursday, July 29, 2021

Wednesday, July 28, 2021

Thursday, July 22, 2021

Tuesday, July 13, 2021

Saturday, June 19, 2021

Wednesday, May 19, 2021

Tuesday, May 18, 2021

Monday, May 10, 2021

Monday, May 3, 2021

Thursday, April 8, 2021